Functional Roles of Nurr1 for Midbrain Dopamine Neurons in Health and Disease

Nurr1 对中脑多巴胺神经元在健康和疾病中的功能作用

基本信息

  • 批准号:
    8759085
  • 负责人:
  • 金额:
    $ 34.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Midbrain dopaminergic (mDA) neurons critically control voluntary movement, reward, and mood-related behaviors, and their degeneration/dysfunction is associated with major brain disorders such as Parkinson's disease (PD) and schizophrenia. Thus, it is critical to understand molecular mechanisms underlying development, survival, and function of mDA neurons in health and disease. During the last funding cycle, we investigated the regulatory networks of key extrinsic factors and intrinsic transcription factors that critically control mDA neuronal development, focusing on the role and regulation of Pitx3. We found that Wnt1-Lmx1a form an autoregulatory pathway leading to induction of key transcription factors, Nurr1 and Pitx3. Notably, these studies revealed that two major pathways controlling mDA neuronal development (i.e., Shh-FoxA2 and Wnt1-Lmx1a) merge on Nurr1, highlighting Nurr1's essential role(s) for mDA neuron development/ maintenance. Indeed, recent studies showed that Nurr1 is critical not only for the development and long-term maintenance of mDA neurons (by transactivation function) but also for their protection from inflammation-induced death (through transrepression of inflammatory genes). Nurr1 is an orphan nuclear receptor and is known as a ligand-independent constitutively active nuclear receptor. Strikingly, however, we recently identified small molecules that can directly interact with the ligand binding domain of Nurr1 stimulating its contrasting dual functions; furthe activating the mDA neuronal function and further transrepressing expression of inflammatory genes in microglia. Based on these promising data identifying potential synthetic ligands/agonists of Nurr1, we hypothesize that Nurr1 may be an "adopted" nuclear receptor and that there may exist an endogenous Nurr1 ligand. Furthermore, Nurr1's diverse functions (e.g., transactivation, transrepression, or no apparent function) appear to depend upon the cellular context, which may be determined by cell-specific Nurr1-interacting factor(s). To address these hypotheses, we will systematically investigate the contrasting dual functions of Nurr1 in the absence and in the presence of agonist molecules and will identify and characterize multiprotein complexes associated with Nurr1 in different cellular contexts and the "putative" endogenous ligand(s). Our proposal is highly novel and innovative and will shed new insights into the functional roles of Nurr1 in mDA neurons, potentially leading to a paradigm-shift of our understanding of Nurr1's functional roles on mDA neurobiology and future therapeutic development of DA-related brain disorders.
描述(由申请人提供):中脑多巴胺能(mDA)神经元严格控制自主运动、奖励和情绪相关行为,其变性/功能障碍与帕金森病(PD)和精神分裂症等主要脑部疾病相关。因此,了解mDA神经元在健康和疾病中的发育、存活和功能的分子机制至关重要。在上一个资助周期中,我们研究了关键外在因子和内在转录因子的调控网络,这些因子关键控制mDA神经元发育,重点关注Pitx 3的作用和调控。我们发现Wnt 1-Lmx 1a形成了一个自动调节通路,导致诱导关键转录因子Nurr 1和Pitx 3。值得注意的是,这些研究揭示了控制mDA神经元发育的两个主要途径(即,Shh-FoxA 2和Wnt 1-Lmx 1a)在Nurr 1上合并,突出了Nurr 1对mDA神经元发育/维持的重要作用。事实上,最近的研究表明,Nurr 1不仅对mDA神经元的发育和长期维持(通过反式激活功能)至关重要,而且对它们免受炎症诱导的死亡(通过炎症基因的反式抑制)也至关重要。Nurr 1是一种孤儿核受体,被称为配体非依赖性组成型活性核受体。然而,引人注目的是,我们最近发现了可以直接与Nurr 1的配体结合结构域相互作用的小分子,刺激其对比鲜明的双重功能;进一步激活mDA神经元功能,并进一步反式抑制小胶质细胞中炎症基因的表达。基于这些有希望的数据识别潜在的合成配体/激动剂的Nurr 1,我们假设,Nurr 1可能是一个“通过”核受体,可能存在一个内源性Nurr 1配体。此外,Nurr 1的多种功能(例如,反式激活、反式阻遏或无明显功能)似乎取决于细胞环境,这可能由细胞特异性Nurr 1相互作用因子决定。为了解决这些假设,我们将系统地研究对比的双重功能的Nurr 1在没有和激动剂分子的存在下,并将确定和表征多蛋白复合物与Nurr 1在不同的细胞环境和“推定的”内源性配体(S)。我们的提议非常新颖和创新,将为Nurr 1在mDA神经元中的功能作用提供新的见解,可能会导致我们对Nurr 1在mDA神经生物学中的功能作用的理解范式转变,以及DA相关脑部疾病的未来治疗开发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kwang-Soo Kim其他文献

Kwang-Soo Kim的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kwang-Soo Kim', 18)}}的其他基金

Human iPSC-Based Personalized Cell Therapy of PD
基于人类 iPSC 的个性化 PD 细胞疗法
  • 批准号:
    10678012
  • 财政年份:
    2023
  • 资助金额:
    $ 34.56万
  • 项目类别:
Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands
Nurr1与帕金森病危险因素的串扰及其配体的调控
  • 批准号:
    10677221
  • 财政年份:
    2023
  • 资助金额:
    $ 34.56万
  • 项目类别:
Crosstalk between Nurr1 and risk factors of Parkinson's disease and its regulation by Nurr1's ligands
Nurr1与帕金森病危险因素的串扰及其配体的调控
  • 批准号:
    10592731
  • 财政年份:
    2022
  • 资助金额:
    $ 34.56万
  • 项目类别:
Functional Roles of Nurr1 in AD Related Pathophysiology
Nurr1 在 AD 相关病理生理学中的功能作用
  • 批准号:
    8891618
  • 财政年份:
    2015
  • 资助金额:
    $ 34.56万
  • 项目类别:
Protein-induced human iPS cells for personalized cell therapy of PD
蛋白质诱导的人类 iPS 细胞用于 PD 个性化细胞治疗
  • 批准号:
    8670784
  • 财政年份:
    2010
  • 资助金额:
    $ 34.56万
  • 项目类别:
Human iPSC-based personalized cell therapy of PD
基于人类 iPSC 的 PD 个性化细胞治疗
  • 批准号:
    9127537
  • 财政年份:
    2010
  • 资助金额:
    $ 34.56万
  • 项目类别:
Protein-induced human iPS cells for personalized cell therapy of PD
蛋白质诱导的人类 iPS 细胞用于 PD 个性化细胞治疗
  • 批准号:
    8079724
  • 财政年份:
    2010
  • 资助金额:
    $ 34.56万
  • 项目类别:
Protein-induced human iPS cells for personalized cell therapy of PD
蛋白质诱导的人类 iPS 细胞用于 PD 个性化细胞治疗
  • 批准号:
    8481598
  • 财政年份:
    2010
  • 资助金额:
    $ 34.56万
  • 项目类别:
Protein-induced human iPS cells for personalized cell therapy of PD
蛋白质诱导的人类 iPS 细胞用于 PD 个性化细胞治疗
  • 批准号:
    7917933
  • 财政年份:
    2010
  • 资助金额:
    $ 34.56万
  • 项目类别:
Patient-specific and universal donor blood cell from protein-induced iPS cells
来自蛋白质诱导的 iPS 细胞的患者特异性和通用供体血细胞
  • 批准号:
    8045716
  • 财政年份:
    2010
  • 资助金额:
    $ 34.56万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.56万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了